Update on emerging urate-lowering therapies (vol 21, pg 143, 2009)

被引：0
|
作者：
Chohan, S.
Becker, M. A.
机构：
来源：
CURRENT OPINION IN RHEUMATOLOGY | 2010年 / 22卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Association between urate-lowering therapy and cardiovascular events in patients with asymptomatic hyperuricemia (vol 42, pg 3075, 2023)
    Hashimoto, Hiroyuki
    Takeuchi, Masato
    Kawakami, Koji
    CLINICAL RHEUMATOLOGY, 2024, 43 (3) : 1271 - 1274
  • [22] Impact of anti-inflammatory therapies, xanthine oxidase inhibitors and other urate-lowering therapies on cardiovascular diseases in gout
    Richette, Pascal
    Frazier, Aline
    Bardin, Thomas
    CURRENT OPINION IN RHEUMATOLOGY, 2015, 27 (02) : 170 - 174
  • [23] Cardiovascular effects of urate-lowering therapies in patients with chronic gout: a systematic review and meta-analysis
    Zhang, Tony
    Pope, Janet E.
    RHEUMATOLOGY, 2017, 56 (07) : 1144 - 1153
  • [24] Cost Comparison of Urate-Lowering Therapies in Patients with Gout and Moderate-to-Severe Chronic Kidney Disease
    Mitri, Ghaith
    Wittbrodt, Eric T.
    Turpin, Robin S.
    Tidwell, Beni A.
    Schulman, Kathy L.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2016, 22 (04): : 326 - 336
  • [25] Existing and Emerging Therapies for Acute Gout and Long-Term Urate Lowering
    Stamp, Lisa K.
    Chapman, Peter T.
    CURRENT RHEUMATOLOGY REVIEWS, 2011, 7 (02) : 141 - 151
  • [26] POLYCHRONIC DISEASE BURDEN IN PATIENTS WITH GOUT AND MODERATE TO SEVERE CHRONIC KIDNEY DISEASE RECEIVING URATE-LOWERING THERAPIES
    Turpin, R.
    Mitri, G.
    Wittbrodt, E.
    Tidwell, B.
    Schulman, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1293 - 1293
  • [27] Risk of Dementia in Patients with Gout and the Impact of Urate-Lowering Therapies: A Large Population-Based Cohort Study
    Crowley, Louise
    Sultan, Alyshah Abdul
    Roddy, Edward
    Mallen, Christian
    Protheroe, Joanne
    Clarson, Lorna
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [28] Trends in utilization of urate-lowering therapies following the US Food and Drug Administration's boxed warning on febuxostat
    Kim, Seoyoung C.
    Neogi, Tuhina
    Kim, Erin
    Lii, Joyce
    Desai, Rishi J.
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 (03) : 542 - 543
  • [29] Response to: 'Use of urate-lowering therapies is not associated with an increase in the risk of incident dementia in older adults' by Lee and Song
    Singh, Jasvinder A.
    Cleveland, John
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (10)
  • [30] Update in cardiology (vol 143, pg 737, 2005)
    Stone, PH
    ANNALS OF INTERNAL MEDICINE, 2006, 144 (03) : 227 - 227
12345